Inhibitor Therapeutics, Inc. (INTI) SEC Filings https://investors.inhibitortx.com/sec-filings/all-sec-filings/rss Inhibitor Therapeutics, Inc. (INTI) - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/_5a8cb0b9c83c9803ac6e80d95e72f0b2/inhibitortx/files/theme/images/logo-sm.png Inhibitor Therapeutics, Inc. Logo Equisolve Investor Relations Suite <![CDATA[DEF 14A - Definitive proxy statements]]> https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-26-038636/0001493152-26-038636.pdf Mon, 17 Aug 26 00:00:00 -0400 https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-26-038636/0001493152-26-038636.pdf <![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]> https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-26-038288/0001493152-26-038288.pdf Fri, 14 Aug 26 00:00:00 -0400 https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-26-038288/0001493152-26-038288.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-26-036080/0001493152-26-036080.pdf Tue, 04 Aug 26 00:00:00 -0400 https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-26-036080/0001493152-26-036080.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-26-035962/0001493152-26-035962.pdf Tue, 04 Aug 26 00:00:00 -0400 https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-26-035962/0001493152-26-035962.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-26-035955/0001493152-26-035955.pdf Tue, 04 Aug 26 00:00:00 -0400 https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-26-035955/0001493152-26-035955.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-26-035953/0001493152-26-035953.pdf Tue, 04 Aug 26 00:00:00 -0400 https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-26-035953/0001493152-26-035953.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-26-035950/0001493152-26-035950.pdf Tue, 04 Aug 26 00:00:00 -0400 https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-26-035950/0001493152-26-035950.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-26-029898/0001493152-26-029898.pdf Wed, 24 Jun 26 00:00:00 -0400 https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-26-029898/0001493152-26-029898.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-26-026623/0001493152-26-026623.pdf Mon, 01 Jun 26 00:00:00 -0400 https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-26-026623/0001493152-26-026623.pdf <![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]> https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-26-023622/0001493152-26-023622.pdf Fri, 15 May 26 00:00:00 -0400 https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-26-023622/0001493152-26-023622.pdf